APOG Stock Cash Flow Statements

Apogee Enterprises Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Apogee Enterprises Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-05-31	2025-03-01	2024-11-30	2024-08-31	2024-06-01	2024-03-02	2023-11-25	2023-08-26	2023-05-27	2023-02-25	2022-11-26	2022-08-27	2022-05-28	2022-02-26	2021-11-27	2021-08-28	2021-05-29	2021-02-27	2020-11-28	2020-08-29	2020-05-30	2020-02-29	2019-11-30	2019-08-31	2019-06-01	2019-03-02	2018-12-01	2018-09-01	2018-06-02	2018-03-03	2017-12-02	2017-09-02	2017-06-03	2017-03-04	2016-11-26	2016-08-27	2016-05-28	2016-02-27	2015-11-28	2015-08-29	2015-05-30	2015-02-28	2014-11-29	2014-08-30	2014-05-31	2014-03-01	2013-11-30	2013-08-31	2013-06-01	2013-03-02	2012-12-01	2012-09-01	2012-06-02	2012-03-03	2011-11-26	2011-08-27	2011-05-28	2011-02-26	2010-11-27	2010-08-28	2010-05-29	2010-02-27	2009-11-28	2009-08-29	2009-05-30	2009-02-28	2008-11-29	2008-08-30	2008-05-31	2008-03-01	2007-12-01	2007-09-01	2007-06-02	2006-12-02	2006-09-02	2006-06-03	2006-02-25	2005-11-26	2005-02-26	2004-11-27	2004-02-28	2003-11-29

operating activities
net earnings	-2,688,000	2,486,000	20,989,000	30,566,000	31,011,000	15,736,000	26,974,000	33,327,000	23,576,000	20,222,000	23,765,000	37,389,000	22,731,000	-16,273,000	11,058,000	-2,116,000	10,817,000	-42,371,000	37,273,000	17,658,000	2,876,000	11,958,000	15,234,000	19,279,000	15,443,000	-12,084,000	21,891,000	20,514,000	15,373,000	22,329,000	23,647,000	17,408,000	16,104,000	23,119,000	22,552,000	22,397,000	17,722,000	19,936,000	18,520,000	14,760,000	12,126,000	13,888,000	13,736,000	16,790,000	6,102,000	8,038,000	9,668,000	6,121,000	4,159,000	4,396,000	8,052,000	5,057,000	1,606,000	2,963,000				-4,410,000	-2,322,000	-121,000	-3,479,000	473,000	10,725,000	13,024,000	7,520,000	10,971,000	17,645,000	12,217,000	10,202,000	14,385,000	10,996,000	11,474,000	11,696,000	9,903,000	7,333,000	4,742,000	5,346,000	8,974,000	3,611,000	5,557,000	-6,499,000	2,450,000
adjustments to reconcile net earnings to net cash from operating activities:
depreciation and amortization	12,436,000	13,810,000	11,134,000	9,688,000	9,976,000	10,403,000	10,524,000	10,379,000	10,282,000	10,478,000	10,477,000	10,599,000	10,849,000	11,640,000	12,545,000	12,828,000	12,980,000	13,440,000	12,716,000	12,744,000	12,540,000	12,114,000	11,922,000	11,657,000	11,102,000	11,420,000	11,921,000	12,407,000	14,050,000	15,069,000	14,712,000	13,639,000	11,423,000	11,337,000	8,315,000	8,235,000	7,720,000	7,912,000	7,834,000	7,761,000	7,741,000	7,865,000	7,815,000	6,977,000	6,766,000	6,974,000	6,401,000	6,664,000	6,511,000	6,712,000	6,704,000	6,585,000	6,528,000	6,631,000	6,739,000	6,854,000	7,022,000	7,690,000	6,753,000	6,802,000	6,973,000	7,443,000	7,340,000	7,526,000	7,292,000	8,268,000	7,734,000	6,692,000	6,613,000	5,805,000	5,557,000	5,751,000	5,663,000	4,864,000	4,945,000	5,168,000	4,345,000	4,189,000	4,545,000	4,375,000	4,680,000	4,895,000
share-based compensation	2,300,000	2,658,000	2,425,000	2,938,000	2,704,000	3,077,000	2,161,000	2,305,000	2,178,000	2,695,000	2,567,000	1,797,000	1,597,000	1,486,000	1,546,000	1,587,000	1,674,000	2,410,000	2,501,000	2,256,000	1,406,000	1,990,000	1,417,000	1,582,000	1,618,000	1,562,000	1,605,000	1,605,000	1,514,000	1,560,000	1,582,000	1,660,000	1,403,000					1,237,000
deferred income taxes	2,496,000	-1,273,000	3,093,000	-1,450,000	3,466,000	-11,044,000	5,577,000	-4,116,000	-165,000	-9,526,000	-4,517,000	2,458,000	4,400,000	-2,544,000	-852,000	-5,501,000	941,000	-11,472,000	-2,954,000	8,704,000	-738,000	375,000	227,000	3,423,000	6,438,000	-16,106,000	4,539,000	1,967,000	4,094,000	6,534,000	-2,588,000	-3,291,000	2,540,000	2,270,000	-2,015,000	-1,697,000	377,000	-1,113,000	-2,774,000	-2,610,000	358,000	5,296,000	-2,642,000	2,121,000	-501,000	-3,056,000	-2,271,000	-229,000	276,000	2,860,000	-137,000	264,000	570,000	-2,927,000	622,000	787,000	403,000	4,043,000	-1,573,000	-2,221,000	-456,000	1,195,000	-868,000	567,000	-131,000	6,142,000	1,995,000	-127,000	318,000	-2,488,000	123,000	-2,000	-231,000	-87,000	18,000	-11,000	-24,000	-1,028,000	1,736,000	-1,253,000	4,291,000	395,000
loss on disposal of property, plant and equipment	328,000
impairment on intangible assets	7,418,000
non-cash lease expense	3,738,000	3,823,000	4,082,000	2,949,000	2,895,000
other	1,294,000	-3,047,000	798,000	1,927,000	-925,000	4,605,000	1,131,000	-689,000	-432,000	699,000	2,047,000	1,701,000	952,000	-4,281,000	2,431,000	520,000	58,000	-2,019,000	-87,000	-1,021,000	1,039,000	491,000	16,000	-261,000	-1,762,000	-1,380,000	-117,000	-242,000	-440,000	-145,000	-118,000	55,000	-1,223,000	-1,050,000	143,000	-1,203,000	-221,000	455,000	13,000	510,000	39,000	235,000	83,000	-101,000	12,000	265,000	-612,000	167,000	231,000	763,000	57,000	97,000	239,000	405,000	13,000	24,000	74,000	148,000	28,000	39,000	65,000	-243,000	100,000	99,000	136,000	-209,000	11,000	36,000	24,000	55,000	62,000	32,000	-29,000	500,000	247,000	312,000	147,000	34,000	638,000	-400,000	-974,000	-13,000
changes in operating assets and liabilities:
receivables	-3,938,000	1,683,000	1,507,000	6,147,000	-9,845,000	24,839,000	7,392,000	5,238,000	-13,476,000	-637,000	7,558,000	-39,089,000	-26,671,000	1,078,000	-9,077,000	11,065,000	4,455,000	-2,523,000	-7,059,000	-8,438,000	39,650,000	1,071,000	3,927,000	7,767,000	-16,982,000	8,873,000	-1,307,000	-15,585,000	26,183,000	34,303,000	-24,814,000	3,558,000	5,125,000	18,695,000	-938,000	-1,072,000	-13,225,000	-9,470,000	-13,346,000	9,078,000	10,820,000	2,109,000	-10,643,000	-10,640,000	586,000	-10,982,000	-5,845,000	-6,184,000	3,782,000	6,142,000	-9,890,000	-6,026,000	-3,590,000	13,059,000	-10,792,000	-4,512,000	-5,686,000	14,211,000	-1,890,000	-2,450,000	-2,291,000	26,388,000	19,498,000	-9,992,000	8,315,000	26,796,000	6,483,000	-512,000	8,003,000	-7,920,000	-8,490,000	-443,000	-4,161,000	-17,626,000	-10,657,000	-1,195,000	4,675,000	-8,235,000	-6,669,000	-9,929,000	5,650,000	-9,840,000
inventories	-11,255,000	2,474,000	2,225,000	828,000	-11,337,000	1,110,000	2,415,000	7,909,000	-2,068,000	7,553,000	11,814,000	108,000	-17,744,000	-5,049,000	950,000	-5,859,000	2,252,000	1,282,000	-3,568,000	5,546,000	-4,700,000	4,668,000	-1,580,000	3,219,000	835,000	716,000	1,651,000	-3,831,000	6,578,000	12,869,000	5,489,000	875,000	-7,712,000	3,168,000	-4,679,000	1,007,000	-5,883,000	621,000	-4,692,000	2,513,000	-1,240,000	-1,345,000	-4,201,000	-846,000	-2,268,000	-1,752,000	-229,000	264,000	-4,413,000	6,463,000	-3,145,000	-723,000	-4,804,000	2,909,000	2,782,000	-1,628,000	-5,698,000	632,000	2,923,000	1,432,000	-5,307,000	534,000	1,873,000	2,854,000	3,692,000	7,630,000	2,604,000	-1,654,000	-1,202,000	-3,057,000	2,528,000	2,264,000	-3,810,000	5,090,000	2,907,000	-5,147,000	-2,607,000	-3,338,000	1,638,000	1,650,000	-596,000	-2,173,000
contract assets	2,596,000	-14,457,000	-8,406,000	-5,273,000	5,511,000	-1,314,000	2,202,000	-5,376,000	14,368,000
accounts payable	1,103,000	2,799,000	5,461,000	3,206,000	-1,871,000	-753,000
accrued compensation and benefits	-16,639,000	9,165,000	-8,135,000	12,027,000	-24,850,000
contract liabilities	8,104,000	-10,901,000	4,512,000	5,339,000	1,648,000	-1,045,000	3,391,000	-3,914,000	8,158,000
operating lease liability	-3,643,000	-3,316,000	-3,639,000	-2,741,000	-3,007,000	-3,418,000	-2,606,000	-3,507,000	-3,101,000	-2,981,000	-2,484,000	-3,351,000	-3,333,000	-3,333,000	-3,147,000	-3,127,000	-3,113,000	-2,345,000	-3,311,000	-3,076,000	-2,781,000
accrued income taxes	1,698,000	1,378,000	-6,274,000	-6,759,000	6,535,000																																																																													-2,824,000
other current assets and liabilities	-25,130,000	14,867,000	1,358,000	-982,000	-6,480,000
net cash from operating activities	-19,782,000	30,032,000	30,998,000	58,679,000	5,453,000	74,902,000				51,584,000				14,180,000	31,384,000	48,024,000	6,883,000	21,351,000	35,182,000			53,661,000	35,799,000			25,779,000	22,715,000	22,586,000	25,343,000	61,224,000	25,430,000	34,897,000	5,912,000	53,520,000	29,273,000	42,066,000	-858,000	37,784,000	24,069,000	41,243,000	20,855,000	31,483,000	20,460,000	15,424,000	1,196,000	10,215,000	30,444,000	14,429,000	-2,167,000	-70,000	-26,000	-63,000	-34,000	-127,000	-37,000	9,000	-3,272,000	-230,000	-174,000	16,000	-78,000	-265,000	-178,000	289,000	-68,000	-13,000	-327,000	-147,000	-84,000	-48,958,000	14,575,000	32,836,000	1,681,000	10,859,000	1,190,000	-162,000	-18,241,000	6,485,000
investing activities
capital expenditures	-7,167,000	-10,897,000	-9,034,000	-8,433,000	-7,229,000	-16,224,000	-11,938,000	-7,620,000	-7,398,000	-27,058,000	-8,864,000	-4,130,000	-5,125,000	-8,771,000	-2,949,000	-5,416,000	-4,705,000	-9,049,000	-2,892,000	-5,618,000	-8,606,000	-10,252,000	-18,617,000	-11,361,000	-11,198,000	-26,850,000	-9,626,000	-14,914,000	-9,327,000	-14,250,000	-12,121,000	-15,395,000	-11,430,000	-23,513,000	-13,074,000	-13,749,000	-17,725,000	-15,280,000	-7,391,000	-10,613,000	-8,753,000	-8,561,000	-5,392,000	-4,529,000	-8,738,000	-24,597,000	-9,019,000	-6,724,000	-1,512,000	-13,399,000	-5,586,000	-6,170,000	-9,509,000	-3,444,000	-2,629,000	-1,963,000	-1,614,000	-1,587,000	-2,520,000	-2,887,000	-2,132,000	-2,083,000	-1,759,000	-3,669,000	-2,254,000	-5,724,000	-10,225,000	-15,945,000	-23,290,000	-16,231,000	-12,947,000	-11,987,000	-14,043,000			-7,904,000			-5,103,000	-3,976,000	-3,609,000	-4,804,000
free cash flows	-26,949,000	19,135,000	21,964,000	50,246,000	-1,776,000	58,678,000				24,526,000				5,409,000	28,435,000	42,608,000	2,178,000	12,302,000	32,290,000			43,409,000	17,182,000			-1,071,000	13,089,000	7,672,000	16,016,000	46,974,000	13,309,000	19,502,000	-5,518,000	30,007,000	16,199,000	28,317,000	-18,583,000	22,504,000	16,678,000	30,630,000	12,102,000	22,922,000	15,068,000	10,895,000	-7,542,000	-14,382,000	21,425,000	7,705,000	-3,679,000	-13,469,000	-5,612,000	-6,233,000	-9,543,000	-3,571,000	-2,666,000	-1,954,000	-4,886,000	-1,817,000	-2,694,000	-2,871,000	-2,210,000	-2,348,000	-1,937,000	-3,380,000	-2,322,000	-5,737,000	-10,552,000	-16,092,000	-23,374,000	-65,189,000	1,628,000	20,849,000	-12,362,000			-8,066,000
proceeds from sales of property, plant and equipment	10,000	-51,000	136,000	568,000	40,000	46,000	104,000	77,000	66,000	2,543,000	1,090,000	35,000	4,087,000	29,252,000	55,000			1,384,000				4,716,000				1,000	11,558,000	68,000	706,000		189,000				3,000						1,000	69,000	3,000	0	201,000	73,000	275,000	289,000	169,000	1,030,000	30,000	4,000	14,000	6,000	1,000	7,000	10,306,000	12,000	9,000	36,000	133,000	180,000	69,000	0	27,000	141,000	36,000	6,000	78,000	118,000	209,000	3,000	24,000	63,000	51,000	1,522,000	-78,000	81,000	15,000	943,000	3,967,000	56,000
purchases of marketable securities		0	-148,000	-1,506,000	-740,000	-1,984,000	0															-2,811,000	-349,000	-2,972,000	-880,000	-207,000	60,000	-447,000	-8,619,000	-90,000	-4,718,000	-3,901,000	-1,535,000	-684,000	-176,000	-202,000	-2,643,000				-35,787,000	-126,000	-4,650,000	-882,000	-484,000	-262,000	-2,620,000	-1,455,000	-10,225,000	-18,010,000	-11,851,000	-11,946,000	-17,040,000	-12,075,000	-7,429,000												-9,466,000	-13,207,000	-15,016,000	-9,775,000	-10,559,000	-9,042,000	-4,887,000	-8,787,000	-13,697,000	-10,444,000	-11,135,000	-12,013,000	-9,922,000	-12,407,000	-2,881,000	-10,711,000
sales/maturities of marketable securities	175,000	1,200,000	520,000	1,250,000	600,000	795,000	595,000	375,000	400,000													2,901,000	345,000	3,410,000	1,112,000	297,000	870,000	2,448,000	2,495,000	1,188,000	5,017,000	1,051,000	3,220,000	32,730,000	1,409,000	402,000	1,892,000				1,696,000	125,000	541,000	5,412,000	868,000	3,103,000	15,058,000	16,203,000	6,656,000	14,373,000	12,529,000	8,478,000	5,915,000	12,873,000	4,414,000											6,893,000	10,699,000	14,393,000	14,971,000	8,693,000	10,465,000	7,794,000	4,272,000	8,656,000	11,036,000	12,870,000	7,802,000	11,373,000	8,977,000	13,614,000	4,045,000	10,385,000
net cash from investing activities	-6,982,000																								-12,022,000	-26,759,000	2,862,000	-13,569,000	-16,230,000	-10,124,000	-11,791,000	-200,967,000	-2,852,000	-124,556,000	-9,897,000	-28,987,000	-20,318,000	13,562,000	-17,926,000	-29,826,000	-43,666,000	-8,153,000	-9,126,000	159,000	-7,355,000	-1,031,000	-64,045,000	6,761,000	14,341,000	-15,782,000	-2,276,000	-9,294,000	-29,780,000		-3,849,000	14,437,000	10,489,000		-13,890,000	18,085,000	-15,527,000		-11,215,000	-9,836,000	-794,000		18,152,000	-14,769,000	-23,265,000	49,147,000	-12,832,000	-13,232,000	-14,634,000	-10,345,000	-7,022,000	-2,706,000	23,284,000	-10,285,000	-12,837,000	-1,826,000	1,498,000	-5,088,000
financing activities
proceeds from revolving credit facilities	59,000,000	-18,000,000	0	65,201,000	30,000,000
repayment on revolving credit facilities	-33,000,000	58,000,000
repurchase of common stock		-30,303,000	0	0	-15,061,000
dividends paid	-5,520,000	-5,499,000	-5,417,000			-5,443,000	-5,223,000	-5,222,000	-5,245,000	-5,255,000	-4,813,000	-4,809,000	-4,793,000	-5,216,000	-4,990,000	-5,025,000	-5,035,000	-5,055,000	-4,795,000	-4,879,000	-4,872,000	-4,906,000	-4,605,000	-4,605,000	-4,598,000	-4,684,000	-4,357,000	-4,413,000	-4,410,000	-4,422,000	-3,977,000	-3,992,000	-4,002,000	-3,980,000	-3,554,000	-3,573,000	-3,560,000	-3,552,000	-3,201,000	-3,216,000	-3,215,000	-3,196,000	-2,899,000	-2,898,000	-3,078,000	-2,896,000	-2,591,000	-2,590,000	-2,687,000	-2,565,000	-2,558,000	-2,550,000	-2,643,000	-2,288,000	-2,286,000			-2,293,000	-2,291,000			-2,279,000	-2,281,000			-2,271,000	-2,283,000			-2,129,000	-2,155,000			-1,909,000	-1,832,000	-3,642,000	-1,707,000	-1,804,000	-1,707,000	-1,696,000	-1,643,000	-1,650,000
net cash from financing activities	17,645,000																									-11,155,000	-19,913,000	5,873,000	-7,131,000	-43,340,000	-29,846,000	171,118,000	402,000	39,150,000	-14,717,000	-3,280,000	-2,491,000	-21,597,000	-10,874,000	-3,507,000	-435,000	-4,817,000	-1,271,000	-8,157,000	-5,528,000	-342,000	-2,117,000	-2,283,000	-12,834,000	-1,437,000	-2,494,000	-2,164,000	6,327,000		-4,640,000	-5,757,000	-890,000		-2,251,000	-4,544,000	10,812,000		-2,040,000	-4,488,000	-1,083,000		-44,091,000	-18,624,000	10,674,000		-5,527,000	-20,436,000	10,601,000	-1,433,000	-4,136,000	13,294,000		1,012,000	-1,618,000	-9,431,000	-5,495,000	-141,000
effect of exchange rates on cash	502,000	-677,000	-168,000	-190,000	-51,000	440,000	-164,000	-482,000	77,000	-423,000	322,000	-36,000	64,000	779,000	-272,000	-97,000	714,000	356,000	131,000	268,000	-270,000	-31,000	-86,000	261,000	-143,000	-21,000	-232,000	-545,000	279,000	-1,246,000	-476,000	1,508,000	47,000	-250,000	-36,000	210,000	164,000	8,000	-746,000	76,000	-735,000	-395,000	-644,000	129,000	315,000	-230,000	-70,000	-413,000	40,000	-34,000	147,000	-107,000	111,000	-63,000	-158,000
decrease in cash, cash equivalents and restricted cash	-8,617,000												-13,776,000
cash, cash equivalents and restricted cash at beginning of period	41,448,000
cash and cash equivalents at end of period	32,831,000	-2,407,000	-7,169,000	20,661,000	30,363,000		4,984,000																							6,514,000	-16,683,000	6,556,000	22,972,000	-32,136,000	4,623,000	10,009,000	36,967,000	29,757,000	-5,477,000	7,986,000	28,204,000	18,118,000	9,419,000	7,555,000	17,093,000	8,612,000	-35,788,000	18,494,000	37,147,000	349,000	7,865,000	6,525,000	23,028,000		1,313,000	14,501,000	10,110,000		-14,606,000	17,068,000	11,790,000		27,084,000	14,556,000	15,806,000		5,261,000	978,000	4,552,000		-2,675,000	6,573,000	3,738,000	-1,237,000	-2,338,000	7,027,000		-2,788,000		4,118,000		-4,216,000
non-cash activity
capital expenditures in accounts payable	922,000	1,014,000	873,000	954,000	472,000	2,357,000	-1,262,000	378,000	2,115,000	1,352,000	-462,000	1,253,000	766,000	1,231,000	721,000	-684,000	1,058,000	417,000	27,000	-801,000	1,458,000	964,000	-378,000	-84,000	1,667,000	-4,068,000	4,015,000	-406,000	2,162,000	-75,000	663,000	-3,005,000	4,201,000	-3,429,000	4,163,000	-935,000	3,455,000	2,366,000	-643,000	-349,000	1,363,000	1,801,000	13,000	-79,000	921,000	-635,000	1,077,000	21,000	298,000	-335,000	85,000	654,000	149,000	371,000	-165,000	166,000	174,000	202,000	-418,000	-75,000	645,000	45,000	211,000	-33,000	88,000	-292,000	-474,000	1,515,000	-620,000	1,512,000	-2,603,000	1,502,000	513,000	137,000	47,000	153,000
dividends declared but not yet paid					5,409,000
asset impairment on property, plant and equipment
gain on disposal of property, plant and equipment		249,000	-132,000	269,000	22,000
proceeds from new markets tax credit transaction, net of deferred costs										0	0	0	18,390,000													0	2,798,000							0	0											-281,000
settlement of new markets tax credit transaction						0	0			0	0	0	-19,523,000
acquisition of business, net of cash acquired		956,000																													0
proceeds from term loans		0
repayment of debt
payments of debt issuance costs		0	-313,000
increase in cash, cash equivalents and restricted cash						13,240,000			3,092,000	-3,568,000	-5,607,000
net cash used by investing activities			-241,651,000	-8,121,000	-7,329,000		-11,239,000	-8,137,000	-6,932,000		-7,301,000	-3,745,000	-938,000			-4,615,000	-4,148,000			-5,529,000	-9,688,000	-5,596,000	-18,432,000
repayment of term loans
net cash provided (used) by financing activities												-17,160,000	17,624,000												21,622,000
increase in cash and cash equivalents			-7,169,000	20,661,000	-6,853,000										16,723,000				36,281,000				-8,829,000	-9,772,000	-142,000	-12,135,000	5,664,000	14,890,000	1,982,000			5,048,000	3,462,000					29,749,000				18,513,000	10,063,000							383,000	7,718,000			28,166,000	1,471,000			10,044,000	-14,606,000	17,068,000	-35,139,000	-10,517,000	27,084,000	14,556,000	2,812,000	2,203,000	5,261,000			4,628,000	-2,675,000	6,573,000	-2,449,000		-2,338,000	2,351,000		-2,788,000
cash and cash equivalents at beginning of period			0	0	37,216,000
repayments on revolving credit facilities				-80,201,000	-15,000,000
net cash used by financing activities				-29,707,000	-4,926,000	-44,166,000				-39,426,000				-76,578,000	-11,777,000	-17,960,000	-14,257,000	-22,178,000	-19,636,000				-26,196,000
asset impairment charges
impairment expense on goodwill and intangible assets
refundable and accrued income taxes						14,110,000	-11,879,000	-3,298,000	7,590,000	7,415,000	6,095,000	-24,724,000	4,238,000	5,762,000	3,274,000	571,000	1,410,000	-9,772,000	14,217,000	-4,640,000	2,847,000	-2,567,000	-518,000	-1,272,000	-4,369,000	1,849,000	-299,000	1,829,000	301,000	-6,793,000	29,000	2,212,000	4,867,000	-8,574,000	237,000	-3,842,000	2,532,000	-570,000	95,000	7,703,000	5,361,000	-4,642,000	8,354,000	-7,628,000	2,825,000	-2,069,000	2,049,000	2,044,000	1,425,000	-2,303,000	524,000	776,000	-3,083,000	10,078,000	800,000	-1,088,000	-1,903,000	-5,119,000	982,000	-116,000	-5,424,000	-7,039,000	6,164,000	844,000	4,011,000	-6,598,000	2,715,000	-1,217,000	-1,913,000	5,525,000	-9,741,000	5,033,000	3,587,000	-383,000	3,906,000	1,956,000	-3,290,000	-931,000	505,000	4,036,000
net cash (used) provided by investing activities
repayment on debt										0	0	-150,000,000	-1,000,000
proceeds from exercise of stock options														0	0	0	4,115,000
cash, cash equivalents and restricted cash at beginning of year						0	0	0	21,473,000	0	0	0	37,583,000	0	0	0	47,277,000	0	0	0	14,952,000	0	0	0	29,241,000	0	0	0	19,359,000
cash and cash equivalents at end of year
gain on disposal of assets							12,000	-35,000	-27,000	-2,331,000	-789,000	-35,000	-660,000	-19,737,000				702,000								24,000	-1,684,000			1,115,000	-41,000			-84,000	-104,000	-29,000	-154,000	-131,000	164,000	-129,000	-102,000	-98,000	-163,000	-219,000	-453,000	-332,000	-483,000	-510,000	-304,000	-1,077,000	-297,000	-284,000	-296,000		-213,000	-289,000	-203,000		-36,000				-21,000	-9,000	6,000	300,000	2,000	-27,000	-54,000	371,000	57,000	-75,000	-75,000	-373,000	-379,000	-1,203,000	-310,000	-57,000	58,000	-507,000	-307,000	-358,000
noncash lease expense							2,589,000	3,439,000	2,714,000	2,954,000	2,764,000	3,072,000	3,088,000	3,116,000	3,086,000	3,118,000	3,098,000	2,704,000	3,499,000	3,087,000	2,945,000	10,895,000	-1,189,000	-188,000	2,902,000
accrued expenses
prepaid expenses and other current assets							4,626,000	3,696,000	-6,608,000
borrowings on line of credit							20,998,000	69,001,000	105,852,000	55,000,000	20,999,000	248,880,000	161,000,000					5,269,000	751,000	53,081,000	139,500,000	121,000,000	-76,500,000	81,500,000	103,000,000	68,500,000	89,500,000	115,000,000	90,000,000	71,000,000	30,500,000	247,200,000	37,000,000						-618,000
payments on line of credit							-66,000,000	-94,000,000	-105,000,000	-88,865,000	-68,000,000	-109,000,000	-62,000,000					-8,840,000	0	-91,000,000	-146,500,000	-154,000,000	55,000,000	-252,000,000	-55,500,000	-55,000,000	-81,500,000	-104,500,000	-92,000,000	-85,040,000	-56,700,000	-63,000,000	-31,000,000
payments on debt issuance costs
repurchase and retirement of common stock							0	-6,628,000	-5,193,000	0	0	0	-74,312,000	-71,250,000	-6,745,000	-9,794,000	-12,625,000	-12,147,000	-16,000,000	0	-4,731,000	-5,130,000	0	0	-20,010,000	-20,013,000				-22,843,000	0			0				-17,654,000				0	0	-6,031,000	-863,000									0												0	-6,586,000	-4,902,000	-3,158,000								-1,647,000		50,000	0
noncash activity
accounts payable and accrued expenses								606,000	-21,702,000	22,191,000	-3,759,000	10,105,000	-18,331,000	-2,092,000	16,335,000	11,554,000	-22,449,000	11,324,000	-6,993,000	-14,588,000	-22,334,000	22,082,000	-3,413,000	-2,210,000	-16,834,000	27,672,000	-4,663,000	4,306,000	-19,715,000	1,822,000	6,533,000	-3,246,000	-30,736,000	15,552,000	9,408,000	13,804,000	-21,315,000	15,969,000	14,012,000	5,413,000	-18,129,000	9,830,000	13,151,000	1,567,000	-11,677,000	7,839,000	15,093,000	7,261,000	-11,911,000	-951,000	13,021,000	10,090,000	-10,476,000	-3,133,000	1,287,000	6,823,000	-8,882,000	6,632,000	-216,000	3,780,000	-20,229,000	-1,343,000	738,000	12,208,000	-24,447,000	-3,913,000	-6,104,000	6,706,000	-25,968,000	18,402,000	4,477,000	9,044,000	-18,073,000	5,501,000	1,582,000	-10,860,000	11,731,000	3,223,000	7,380,000	4,573,000	1,135,000	7,747,000
net cash provided (used) by operating activities								41,277,000	21,287,000												23,976,000
payments on debt issue costs											-103,000																															-211,000				-48,000	-44,000			-59,000	-380,000	-1,000	-193,000		-93,000	-34,000	-32,000		-1,000	0	-262,000	-1,000															0	-79,000
net cash (used) provided by financing activities								-38,877,000	-11,263,000												-17,334,000
cash, cash equivalents and restricted cash at end of period									24,642,000	-3,991,000	-5,285,000	6,878,000	23,871,000		16,451,000	25,352,000	36,469,000		36,412,000	7,365,000	11,636,000		-8,915,000	-9,511,000	28,956,000	-12,156,000	5,432,000	14,345,000	21,620,000
asset impairment															1,235,000
costs and earnings on contracts in excess of billings										-613,000	-3,439,000	6,165,000	-5,325,000	-2,065,000	-2,044,000	2,007,000	1,205,000	-318,000	1,410,000	35,533,000	7,558,000	-1,312,000	2,709,000	-13,858,000	-6,007,000	5,857,000	-15,378,000	-3,933,000	-35,258,000
billings in excess of costs and earnings on uncompleted contracts										-3,417,000	-167,000	23,203,000	-2,152,000																	-26,410,000	5,050,000	-290,000	5,109,000	-14,887,000	-5,815,000	198,000	10,513,000	2,266,000	4,227,000	-4,027,000	7,191,000	-3,231,000	-5,200,000	7,122,000	985,000	6,589,000	-1,735,000	-1,601,000	-2,051,000	-4,907,000	-2,254,000	756,000	5,210,000	2,794,000	1,665,000	-1,462,000	-3,853,000	-8,932,000	-4,506,000	-787,000	-1,105,000	-7,714,000	-6,403,000	-641,000	-1,351,000	-5,847,000	2,123,000	9,538,000	9,524,000	2,869,000	6,136,000	4,534,000	6,285,000	4,458,000	273,000	-95,000	-3,092,000	4,898,000	-3,042,000	4,531,000	1,258,000	-186,000
adjustments to reconcile net earnings to net cash (used) provided by operating activities:
net cash (used) provided by operating activities												27,819,000	-30,462,000												-9,742,000
net cash provided (used) by investing activities
(repayment) borrowings on debt																		0	0
cash, cash equivalents and restricted cash at end of year
billings on contracts in excess of costs and earnings															-2,330,000	4,290,000	-6,434,000		2,124,000	8,076,000	-17,181,000		6,902,000	-803,000	-1,198,000		2,109,000	516,000	11,933,000
repayments on debt															0
(gain) loss on disposal of assets																																																													-131,000
decrease in cash and cash equivalents																	-11,522,000				-3,046,000														4,659,000	9,799,000	-23,667,000			7,910,000	-23,246,000				-11,687,000				-660,000				-31,110,000				-14,209,000												-7,712,000													-4,216,000
acquisition of business and intangibles
proceeds from issuance of term debt																						0	0
deferred payments on acquisition of business																														0	0
shares withheld for taxes, net of stock issued to employees																										60,000	-160,000	2,000	-1,433,000	-151,000	51,000	-16,000	-1,596,000	464,000	46,000	242,000	-1,198,000	13,000	-89,000	-1,150,000	-2,028,000	-290,000	92,000	-543,000	-3,164,000		400,000	-220,000	-1,141,000		293,000	263,000	-817,000	555,000	9,000	-94,000	-658,000
change in restricted cash																														0	0	2,683,000	5,151,000	7,050,000	2,065,000
borrowings (payments) on debt
cash and cash equivalents at beginning of year																														0	0	0	19,463,000	0	0	0	60,470,000	0	0	0	52,185,000	0	0	0	28,465,000	0	0	0	37,767,000	0	0	0	54,027,000	0	0	0	24,302,000	0	0	0	46,929,000	0	0	0	12,994,000	0	0	0	12,264,000	0	0	0	6,187,000	0	0	4,676,000	0	0	0	0	0	0
payments on debt																																									-10,000	-12,000	-13,000	-13,000	-12,000	-14,000	-39,000	-14,000	-10,015,000	-39,000	-39,000	-41,000	-45,000	-150,000	-37,000	-1,050,000	-200,000
stock-based compensation																																			1,468,000	1,545,000	1,390,000			1,374,000	1,040,000	1,088,000	1,123,000	1,332,000	1,250,000	1,190,000	1,165,000	1,188,000	1,118,000	881,000	1,196,000	1,290,000	1,028,000	1,069,000	1,331,000	1,602,000	410,000	1,451,000	1,132,000	1,601,000	1,031,000	2,989,000	1,339,000	1,327,000	400,000	801,000	-1,455,000	1,981,000	1,541,000	1,759,000	2,028,000	2,203,000	1,384,000	1,719,000	1,271,000	1,178,000
excess tax benefits from share-based compensation																																			0	-1,960,000	-374,000	-2,000
(repayments) borrowings on line of credit																																			-392,000
proceeds from issuance of debt																																					1,893,000				1,199,000		1,156,000							0	0	0	10,000,000	0
acquisition of businesses and intangibles, net of cash acquired																																														-495,000
purchases of restricted investments																																														0	-33,400,000	0	-2,800,000	0	0	0	-10,000,000	-299,000	0					0	-11,839,000
sales/maturities of restricted investments																																														21,147,000	16,312,000	603,000	22,053,000	224,000	3,168,000	340,000	1,740,000	360,000	1,804,000
sales of restricted investments																																											483,000	786,000	798,000
purchases of securities																																							-7,633,000
sales/maturities of securities																																							81,000
excess tax benefits from stock-based compensation																																								-1,080,000	-3,619,000	-712,000	-397,000	-538,000	-1,589,000	-945,000	-157,000	-614,000	-1,009,000	-103,000	-190,000	-165,000	-25,000	-54,000								-38,000	-62,000	-3,000	-59,000	-43,000	-1,000	-31,000	-1,188,000	-350,000	-108,000	-965,000	-1,142,000	-209,000	-935,000	-347,000
investments in corporate-owned life insurance policies																																									-823,000	-125,000	-111,000							0	-551,000	0	-900,000	0	0
net proceeds from revolving credit agreement																																																																					15,200,000				8,000,000	-300,000	-3,400,000	14,700,000
stock issued to employees, net of shares withheld																																																										-446,000	41,000	33,000	-926,000	21,000	184,000	61,000	-1,142,000	-489,000	77,000	193,000	-2,556,000
net (earnings) income from discontinued operations																																																														-190,000	0							-292,000	-3,431,000	313,000	-1,971,000
net cash from continuing operating activities																																																		17,672,000	12,514,000	18,153,000	-7,623,000	32,701,000	9,997,000	5,819,000	-20,536,000	17,141,000	1,709,000	3,511,000	-30,346,000	23,369,000	40,517,000	28,591,000	4,757,000	45,290,000	31,527,000	34,518,000	4,963,000				-3,174,000			-8,075,000			10,231,000	13,292,000	11,168,000	3,913,000
acquisition of intangibles																																																		0				0	-10,000				0	0	-10,000
acquisition of businesses, net of cash acquired																																																																		-33,000	-3,000	-16,000	-8,000
cash flows of discontinued operations
net cash from discontinued operations																																																		-70,000	-26,000	-63,000	-34,000	-127,000	-37,000	9,000	-3,272,000	-230,000	-174,000	16,000	-78,000	-265,000	-178,000	289,000	-68,000	-13,000	-327,000	-147,000	-84,000	166,000	1,109,000	2,550,000	4,758,000
net earnings from discontinued operations																																																			-1,000								0
dividends in accounts payable																																																									2,287,000				2,287,000				2,274,000				2,131,000				1,949,000
net income (earnings) from discontinued operations																																																																		-23,000	32,000	74,000	77,000
net cash from continuing investing activities
payments of debt issue costs
net cash from continuing financing activities
net income																																																								-1,677,000	-2,177,000
net proceeds from issuance of debt																																																											0	0	12,000,000
adjustments to reconcile net income to net cash from operating activities:
sales (purchases) of restricted investments																																																									619,000
purchases of short-term investments and marketable securities																																																									-6,341,000	-183,000	-5,271,000	-5,750,000	-17,826,000	-37,979,000	-14,224,000	-12,439,000	-6,572,000
sales/maturities of short-term investments and marketable securities																																																									8,954,000	22,121,000	15,054,000	26,686,000	16,147,000	8,732,000	4,699,000	6,272,000	8,005,000
investments in life insurance policies																																																									-1,435,000
effect of exchange rate on cash																																																									17,000
results from equity method investee
proceeds from sale of investment in affiliated company																																																																		0
investment in restricted assets
net payments on revolving credit facility
changes in operating assets and liabilities, net of effect of acquisition:
purchases of restricted investments, net of proceeds from sales
loss on disposal of assets
changes in operating assets and liabilities, net of effect of acquisitions and dispositions:
acquisition of intangibles and businesses, net of cash acquired
net (payments on) proceeds from revolving credit agreement																																																																							-3,700,000
results from equity-method investee
net payments on revolving credit agreement																																																																															150,000
equity in loss of affiliated companies																																																																					379,000				17,000							82,000
net income from discontinued operations
proceeds on note from equity investments																																																																										0	3,750,000	1,250,000
equity in loss (income) of affiliated companies
net proceeds from (payments on) revolving credit agreement																																																																													1,200,000
proceeds on note from (loans to) equity investments
payments on long-term debt																																																																													0	0	-150,000	0	-150,000	0
proceeds from issuance of common stock, net of cancellations																																																																						-201,000	220,000	1,607,000	1,459,000	635,000	161,000	1,889,000	1,797,000		39,000	465,000	-510,000	-138,000
proceeds on note from equity-method investee
equity in earnings of affiliated companies																																																																										-1,080,000
capital expenditures and acquisition of intangible assets																																																																										-10,277,000			-7,245,000	-9,726,000
net cash used by discontinued operations																																																																										-318,000	-283,000	-162,000
equity in loss (earnings) of affiliated companies																																																																												190,000
amortization of deferred compensation - restricted stock
equity in (earnings) loss of affiliate companies
changes in operating assets and liabilities, net of effect of acquisitions:
investments in and loans to equity investments
equity in (earnings) loss of affiliated companies																																																																														-1,124,000
liabilities of discontinued operations																																																																														-222,000
investments in equity investments																																																																															0	0		-14,000
proceeds from issuance of common stock and exercise of stock options
cash from discontinued operations																																																																															621,000	2,083,000	-4,163,000	-2,900,000
equity in loss of affiliate companies
proceeds from issuance of long-term debt
net (income) income from discontinued operations																																																																																0
(investments in) dividends received from equity investments
supplemental schedule of non-cash investing activities:
net assets acquired through assumption of debt
income from equity-method investments																																																																																		816,000
payments on net borrowings under revolving credit agreement																																																																																		1,300,000
payments on deferred debt expense
income from equity investments
increase in (payments on) net borrowings under revolving credit agreement
proceeds from issuance of common stock
results from equity investments
net assets contributed to ppg auto glass, llc
proceeds from sale of property, plant and equipment
change in net borrowings under revolving credit agreement
increase in deferred debt expense

We provide you with 20 years of cash flow statements for Apogee Enterprises stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Apogee Enterprises stock. Explore the full financial landscape of Apogee Enterprises stock with our expertly curated income statements.

The information provided in this report about Apogee Enterprises stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.